Crossmark Global Holdings Inc. Purchases 308 Shares of Exponent, Inc. (NASDAQ:EXPO)

Crossmark Global Holdings Inc. grew its position in Exponent, Inc. (NASDAQ:EXPOFree Report) by 9.5% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,535 shares of the business services provider’s stock after acquiring an additional 308 shares during the period. Crossmark Global Holdings Inc.’s holdings in Exponent were worth $407,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. Comerica Bank increased its position in Exponent by 8.7% during the first quarter. Comerica Bank now owns 231,131 shares of the business services provider’s stock worth $19,112,000 after buying an additional 18,429 shares during the last quarter. Silvercrest Asset Management Group LLC raised its stake in Exponent by 6.8% in the 1st quarter. Silvercrest Asset Management Group LLC now owns 276,500 shares of the business services provider’s stock valued at $22,864,000 after acquiring an additional 17,496 shares during the period. Raymond James & Associates lifted its holdings in Exponent by 4.1% during the 2nd quarter. Raymond James & Associates now owns 487,035 shares of the business services provider’s stock valued at $46,327,000 after purchasing an additional 19,051 shares during the last quarter. Vanguard Group Inc. boosted its position in Exponent by 5.8% during the first quarter. Vanguard Group Inc. now owns 5,286,652 shares of the business services provider’s stock worth $437,153,000 after purchasing an additional 291,047 shares during the period. Finally, &PARTNERS acquired a new position in shares of Exponent in the second quarter valued at $501,000. 92.37% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other Exponent news, Director Paul R. Johnston sold 7,000 shares of Exponent stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $103.83, for a total value of $726,810.00. Following the completion of the transaction, the director now directly owns 80,742 shares of the company’s stock, valued at $8,383,441.86. The trade was a 7.98 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Carol Lindstrom sold 1,039 shares of the stock in a transaction on Monday, November 4th. The stock was sold at an average price of $96.32, for a total value of $100,076.48. Following the sale, the director now directly owns 5,871 shares in the company, valued at approximately $565,494.72. This trade represents a 15.04 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 22,039 shares of company stock valued at $2,291,286. 2.10% of the stock is owned by company insiders.

Exponent Trading Down 1.2 %

Shares of NASDAQ EXPO opened at $97.40 on Friday. The firm has a market cap of $4.94 billion, a P/E ratio of 47.05 and a beta of 0.69. The business’s 50 day moving average is $107.23 and its 200-day moving average is $102.04. Exponent, Inc. has a 1-year low of $68.70 and a 1-year high of $115.75.

Exponent Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, December 20th. Stockholders of record on Friday, December 6th will be issued a dividend of $0.28 per share. This represents a $1.12 dividend on an annualized basis and a dividend yield of 1.15%. The ex-dividend date of this dividend is Friday, December 6th. Exponent’s dividend payout ratio is currently 54.11%.

Wall Street Analyst Weigh In

Separately, Truist Financial reaffirmed a “buy” rating and set a $120.00 target price (up previously from $100.00) on shares of Exponent in a report on Friday, July 26th.

Check Out Our Latest Analysis on EXPO

About Exponent

(Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

Read More

Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPOFree Report).

Institutional Ownership by Quarter for Exponent (NASDAQ:EXPO)

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.